SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ViroPharma Incorporated and Halozyme Therapeutics, Inc. Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) With Recombinant Human Hyaluronidase (rHuPH20)